BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
9.00
-0.14 (-1.53%)
Nov 25, 2025, 4:00 PM EST - Market closed
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $322.7 million as of November 26, 2025. Its market cap has decreased by -56.35% in one year.
Market Cap
322.70M
Enterprise Value
33.97M
1-Year Change
-56.35%
Ranking
Category
Stock Price
$9.00
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $322.70M, a decrease of -47.53%. That is a compound annual growth rate of -42.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 327.72M | 57.89% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |